Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Revenue

In the fiscal year ending March 31, 2026, Neuland Laboratories had annual revenue of 20.53B INR with 39.02% growth. Neuland Laboratories had revenue of 7.89B in the quarter ending March 31, 2026, with 140.20% growth.

• Revenue: 20.53B
• Revenue Growth: +39.02%
• P/S Ratio: 10.28
• Revenue / Employee: 11.44M
• Employees: 1,794
• Market Cap: 211.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	20.53B	5.76B	39.02%
Mar 31, 2025	14.77B	-817.43M	-5.24%
Mar 31, 2024	15.59B	3.67B	30.81%
Mar 31, 2023	11.91B	2.40B	25.20%
Mar 31, 2022	9.52B	147.07M	1.57%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error